Company
March Biosciences
Transforming Patient Care by Unlocking New Target Spaces
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Houston, TX, United States
- Legal name
- march.biosciences
Claim, correct or request removal
Record updated 28 September 2026
About
march.biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers
Funding snapshot
- Total raised
- $22.1MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $22.1M2024-10-07
Funding rounds
- Round, 2024
- $22.1M2024-10-07, SEC form D sold, 22 investors
- Round, 2023
- $8.9K2023-09-01, SEC form D sold, 1 investor
Products
- Other
- MB-105
- Web
- MB-105
Loading relationship preview